Article
Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.
Journal of virology - 1 Oct 1994
Schlienger K, Montefiori D C, Mancini M, Rivière Y, Tiollais P, Michel M L
Abstract excerpt
The potential of the simian immunodeficiency virus (SIV) variable 2 (V2) domain as an effective region to boost SIV-neutralizing antibodies and to protect against live SIV challenge was tested in rhesus macaques. In this study, two rhesus macaques were primed with vaccinia virus recombinants expr...
Topics
- Amino Acid Sequence
- Animals
- Antibodies, Viral
- Antibody Formation
- Antibody Specificity
- Cytotoxicity, Immunologic
- Enzyme-Linked Immunosorbent Assay
- Epitopes
- Genetic Variation
- Macaca mulatta
- Molecular Sequence Data
- Neutralization Tests
- Recombinant Proteins
